retatrutide phase 2 trial results weight loss just delivered the first top-line 3 for a triple agonist in obesity — and the findings from TRIUMPH-4 are striking👇 Results of a new medication,

Mochi Health: Membership and medication refund terms should always be reviewed at checkout, especially when promotional first-month pricing is active

Injection site reactions Injection site reactions are typically mild and temporary side effects of retatrutide

Hypotension consider reducing antihypertensive medicines before initiating treatment or before a dose increase Diabetic ketoacidosis (DKA) increased risk (see below) SGLT-2 inhibitor use is associated with an increased risk of severe DKA People taking SGLT-2 inhibitors are at increased risk of DKA, particularly in the first few months of treatment or peri-operatively

Some patients alternate between the two